Moleculin Biotech(GB:0K2H)
$5.320.00 (0.00%)
GB:0K2H
Moleculin Biotech financials statements
$5.32
At close:0.00 (0.00%)
Moleculin Biotech (0K2H) Income Statement
0 Followers
Moleculin Biotech Income Statement
Last quarter (Q3 2026), Moleculin Biotech's total revenue was $0.00. In Q3, Moleculin Biotech's net income was $-6.49M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -90.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 25.10M | $ 26.64M | $ 29.63M | $ 30.64M | $ 22.97M | |
| Depreciation and Amortization | $ 90.00K | $ 126.00K | $ 127.00K | $ 130.00K | $ 164.00K |
| $ -33.47M | $ -21.64M | $ -29.64M | $ -28.89M | $ -15.73M | |
| $ -25.10M | $ -26.64M | $ -29.63M | $ -30.64M | $ -22.97M | |
| $ -8.46M | $ 4.88M | $ -138.00K | $ 1.61M | $ 7.07M | |
| $ -33.56M | $ -21.76M | $ -29.77M | $ -29.02M | $ -15.89M | |
| $ -33.56M | $ -21.76M | $ -29.77M | $ -29.02M | $ -15.89M | |
| Per Share Metrics | |||||
| Basic EPS | $ -568.40 | $ -3782.80 | $ -7534.20 | $ -7610.20 | $ -4435.40 |
| Diluted EPS | $ -568.40 | $ -3782.80 | $ -7534.20 | $ -7610.20 | $ -4435.40 |
| Weighted Average Shares Outstanding | 59.23K | 6.89K | 3.95K | 3.81K | 3.58K |
| Weighted Average Shares Outstanding (Diluted) | 59.23K | 6.89K | 3.95K | 3.81K | 3.58K |
Currency in USD
